Eupraxia Pharmaceuticals begins trading on Nasdaq Global Select Market after uplisting from Nasdaq Capital Market
EPRX•Nasdaq uplisting
Eupraxia Pharmaceuticals’ common shares began trading on the Nasdaq Global Select Market, shifting from the Nasdaq Capital Market.
The stock continues to trade under ticker EPRX.
Its Toronto Stock Exchange listing remains unchanged.
No shareholder action is required for the transfer.
